ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A950. A total of 4 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,238,707 | +23.2% | 46,100 | +63.5% | 0.00% | – |
| Q2 2023 | $1,005,612 | +335.1% | 28,200 | +209.9% | 0.00% | – |
| Q1 2023 | $231,140 | -92.4% | 9,100 | -87.9% | 0.00% | -100.0% |
| Q4 2022 | $3,054,168 | -1.6% | 75,300 | -19.8% | 0.00% | 0.0% |
| Q3 2022 | $3,103,000 | +1.4% | 93,900 | +8.1% | 0.00% | 0.0% |
| Q2 2022 | $3,060,000 | – | 86,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 9,100 | $231,140 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,300 | $83,820 | 0.00% |
| SIMPLEX TRADING, LLC | 7,800 | $198 | 0.00% |